- Home
- Publications
- Publication Search
- Publication Details
Title
APLAR rheumatoid arthritis treatment recommendations
Authors
Keywords
-
Journal
International Journal of Rheumatic Diseases
Volume 18, Issue 7, Pages 685-713
Publisher
Wiley
Online
2015-09-05
DOI
10.1111/1756-185x.12754
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- State of the art: Reproduction and pregnancy in rheumatic diseases
- (2015) Monika Østensen et al. AUTOIMMUNITY REVIEWS
- Tumour necrosis factor inhibitors versus combination intensive therapy with conventional disease modifying anti-rheumatic drugs in established rheumatoid arthritis: TACIT non-inferiority randomised controlled trial
- (2015) D. L. Scott et al. BMJ-British Medical Journal
- Tumour necrosis factor inhibitors versus combination intensive therapy with conventional disease modifying anti-rheumatic drugs in established rheumatoid arthritis: TACIT non-inferiority randomised controlled trial
- (2015) D. L. Scott et al. BMJ-British Medical Journal
- Aiming for SDAI remission versus low disease activity at 1 year after inclusion in ESPOIR cohort is associated with better 3-year structural outcomes
- (2014) Adeline Ruyssen-Witrand et al. ANNALS OF THE RHEUMATIC DISEASES
- Japan College of Rheumatology 2009 guidelines for the use of tocilizumab, a humanized anti-interleukin-6 receptor monoclonal antibody, in rheumatoid arthritis
- (2014) Ryuji Koike et al. Modern Rheumatology
- Efficacy and safety of additional use of tacrolimus in patients with early rheumatoid arthritis with inadequate response to DMARDs—a multicenter, double-blind, parallel-group trial
- (2014) Shinichi Kawai et al. Modern Rheumatology
- Tofacitinib in Combination With Nonbiologic Disease-Modifying Antirheumatic Drugs in Patients With Active Rheumatoid Arthritis
- (2013) Joel Kremer et al. ANNALS OF INTERNAL MEDICINE
- EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update
- (2013) Josef S Smolen et al. ANNALS OF THE RHEUMATIC DISEASES
- Tofacitinib (CP-690,550) in patients with rheumatoid arthritis receiving methotrexate: Twelve-month data from a twenty-four-month phase III randomized radiographic study
- (2013) Désirée van der Heijde et al. ARTHRITIS AND RHEUMATISM
- Tofacitinib (CP-690,550) in combination with methotrexate in patients with active rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitors: a randomised phase 3 trial
- (2013) Gerd R Burmester et al. LANCET
- Post-marketing surveillance of the safety and effectiveness of tacrolimus in 3,267 Japanese patients with rheumatoid arthritis
- (2013) Tsutomu Takeuchi et al. Modern Rheumatology
- Therapies for Active Rheumatoid Arthritis after Methotrexate Failure
- (2013) James R. O'Dell et al. NEW ENGLAND JOURNAL OF MEDICINE
- German guidelines for the sequential medical treatment of rheumatoid arthritis with traditional and biologic disease-modifying antirheumatic drugs
- (2013) Katinka Albrecht et al. RHEUMATOLOGY INTERNATIONAL
- Consensus statement on blocking the effects of interleukin-6 and in particular by interleukin-6 receptor inhibition in rheumatoid arthritis and other inflammatory conditions
- (2012) Josef S Smolen et al. ANNALS OF THE RHEUMATIC DISEASES
- A randomized comparative effectiveness study of oral triple therapy versus etanercept plus methotrexate in early aggressive rheumatoid arthritis: The Treatment of Early Aggressive Rheumatoid Arthritis trial
- (2012) Larry W. Moreland et al. ARTHRITIS AND RHEUMATISM
- Canadian Rheumatology Association Recommendations for the Pharmacological Management of Rheumatoid Arthritis with Traditional and Biologic Disease-modifying Antirheumatic Drugs: Part II Safety
- (2012) CLAIRE BOMBARDIER et al. JOURNAL OF RHEUMATOLOGY
- Conventional combination treatment versus biological treatment in methotrexate-refractory early rheumatoid arthritis: 2 year follow-up of the randomised, non-blinded, parallel-group Swefot trial
- (2012) Ronald F van Vollenhoven et al. LANCET
- Placebo-Controlled Trial of Tofacitinib Monotherapy in Rheumatoid Arthritis
- (2012) Roy Fleischmann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tofacitinib or Adalimumab versus Placebo in Rheumatoid Arthritis
- (2012) Ronald F. van Vollenhoven et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cancer Risk of Anti-TNF-α at Recommended Doses in Adult Rheumatoid Arthritis: A Meta-Analysis with Intention to Treat and per Protocol Analyses
- (2012) Guillaume Moulis et al. PLoS One
- 2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis
- (2012) Jasvinder A. Singh et al. ARTHRITIS CARE & RESEARCH
- Consenso 2012 da Sociedade Brasileira de Reumatologia para o tratamento da artrite reumatoide
- (2012) Licia Maria Henrique da Mota et al. Revista Brasileira De Reumatologia
- Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis
- (2011) M. H. Buch et al. ANNALS OF THE RHEUMATIC DISEASES
- Anti-TNF therapies and pregnancy: outcome of 130 pregnancies in the British Society for Rheumatology Biologics Register
- (2011) S. M. M. Verstappen et al. ANNALS OF THE RHEUMATIC DISEASES
- Tumor necrosis factor therapy and the risk of serious infection and malignancy in patients with early rheumatoid arthritis: A meta-analysis of randomized controlled trials
- (2011) Andrew E. Thompson et al. ARTHRITIS AND RHEUMATISM
- Canadian Rheumatology Association Recommendations for Pharmacological Management of Rheumatoid Arthritis with Traditional and Biologic Disease-modifying Antirheumatic Drugs
- (2011) VIVIAN P. BYKERK et al. JOURNAL OF RHEUMATOLOGY
- The Pathogenesis of Rheumatoid Arthritis
- (2011) Iain B. McInnes et al. NEW ENGLAND JOURNAL OF MEDICINE
- BSR and BHPR guidelines on the use of rituximab in rheumatoid arthritis
- (2011) M. Bukhari et al. RHEUMATOLOGY
- Quantifying the economic burden of productivity loss in rheumatoid arthritis
- (2011) I. Filipovic et al. RHEUMATOLOGY
- Current evidence for a strategic approach to the management of rheumatoid arthritis with disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis
- (2010) R. Knevel et al. ANNALS OF THE RHEUMATIC DISEASES
- Current evidence for the management of rheumatoid arthritis with glucocorticoids: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis
- (2010) S. L. Gorter et al. ANNALS OF THE RHEUMATIC DISEASES
- Current evidence for the management of rheumatoid arthritis with synthetic disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis
- (2010) C. Gaujoux-Viala et al. ANNALS OF THE RHEUMATIC DISEASES
- EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs
- (2010) J. S. Smolen et al. ANNALS OF THE RHEUMATIC DISEASES
- Treating rheumatoid arthritis to target: recommendations of an international task force
- (2010) J. S. Smolen et al. ANNALS OF THE RHEUMATIC DISEASES
- AGREE II: advancing guideline development, reporting and evaluation in health care
- (2010) M. C. Brouwers et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Management of rheumatoid arthritis: consensus recommendations from the Hong Kong Society of Rheumatology
- (2010) Chi Chiu Mok et al. CLINICAL RHEUMATOLOGY
- Indications of glucocorticoids in early arthritis and rheumatoid arthritis: Recommendations for clinical practice based on data from the literature and expert opinion
- (2010) Gaël Mouterde et al. JOINT BONE SPINE
- Canadian Recommendations for Use of Methotrexate in Patients with Rheumatoid Arthritis
- (2010) W. KATCHAMART et al. JOURNAL OF RHEUMATOLOGY
- Tumour necrosis factor antagonists and the risk of cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review
- (2010) S. L. Westlake et al. RHEUMATOLOGY
- BSR and BHPR rheumatoid arthritis guidelines on eligibility criteria for the first biological therapy
- (2010) C. Deighton et al. RHEUMATOLOGY
- Multicenter, randomized, double-blind, controlled trial of treatment of active rheumatoid arthritis with T-614 compared with methotrexate
- (2009) Liang-jing Lu et al. ARTHRITIS AND RHEUMATISM
- The health-related quality of life in rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis: a comparison with a selected sample of healthy people
- (2009) Fausto Salaffi et al. Health and Quality of Life Outcomes
- Management of T-cell and natural-killer-cell neoplasms in Asia: consensus statement from the Asian Oncology Summit 2009
- (2009) Yok-Lam Kwong et al. LANCET ONCOLOGY
- British Society for Rheumatology and British Health Professionals in Rheumatology guideline for the management of rheumatoid arthritis (after the first 2 years)
- (2009) R. Luqmani et al. RHEUMATOLOGY
- Etanercept therapy in rheumatoid arthritis and the risk of malignancies: a systematic review and individual patient data meta-analysis of randomised controlled trials
- (2008) T Bongartz et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy and toxicity of methotrexate (MTX) monotherapy versus MTX combination therapy with non-biological disease-modifying antirheumatic drugs in rheumatoid arthritis: a systematic review and meta-analysis
- (2008) W Katchamart et al. ANNALS OF THE RHEUMATIC DISEASES
- Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative
- (2008) K Visser et al. ANNALS OF THE RHEUMATIC DISEASES
- American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis
- (2008) Kenneth G. Saag et al. ARTHRITIS AND RHEUMATISM
- Does tumor necrosis factor α inhibition promote or prevent heart failure in patients with rheumatoid arthritis?
- (2008) Joachim Listing et al. ARTHRITIS AND RHEUMATISM
- DMARDS and infections in rheumatoid arthritis
- (2008) Roberto Caporali et al. AUTOIMMUNITY REVIEWS
- Racial/ethnic variation in EBV-positive classical Hodgkin lymphoma in California populations
- (2008) Sally L. Glaser et al. INTERNATIONAL JOURNAL OF CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search